What's in Valenta Pharm JSC's pipeline?

Valenta Pharm JSC has 15 drugs in our index: 4 marketed, 0 filed, 3 in Phase 3, 2 in Phase 2, 6 in Phase 1.

Which companies overlap with Valenta Pharm JSC's portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/valenta-pharm-jsc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Valenta Pharm JSC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Valenta Pharm JSC pipeline: 4 marketed, 0 filed, 3 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 3 Phase 3 2 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Afobazole	Afobazole	marketed			Other
Ranquilon	Ranquilon	marketed			Other
Vespireit	Vespireit	marketed			Other
Arlevert	Arlevert	marketed			Other
Imidazolyl ethanamide pentandioic acid	Imidazolyl ethanamide pentandioic acid	phase 3
XC8	XC8	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Hydroxymethylquinoxalindioxyde	Hydroxymethylquinoxalindioxyde	phase 3

Therapeutic area mix

Other · 6
Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Valenta Pharm JSC:

Cite this brief

Drug Landscape (2026). Valenta Pharm JSC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/valenta-pharm-jsc. Accessed 2026-06-10.